|
|
|
|
Anticoagulant treatment in patients with cerebral sinus thrombosis appears to be safe and is associated with an apparent reduction in the risk of death or dependency, which did not reach statistical significance. In the absence of more information from randomized trials, clinicians will need to base their treatment decisions on the limited information available. |
|